These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38852161)

  • 1. Salivary calprotectin and neutrophils in inflammatory bowel disease in relation to oral diseases.
    Majster M; Almer S; Malmqvist S; Johannsen A; Lira-Junior R; Boström EA
    Oral Dis; 2024 Jun; ():. PubMed ID: 38852161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary calprotectin is elevated in patients with active inflammatory bowel disease.
    Majster M; Almer S; Boström EA
    Arch Oral Biol; 2019 Nov; 107():104528. PubMed ID: 31442931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Calprotectin Is not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease.
    Bos V; Crouwel F; Waaijenberg P; Bouma G; Duijvestein M; Buiter HJ; Brand HS; Hamer HM; De Boer NK
    J Gastrointestin Liver Dis; 2022 Sep; 31(3):283-289. PubMed ID: 36004414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
    Konikoff MR; Denson LA
    Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of serum calprotectin in assessing inflammatory bowel disease activity].
    Mao JY; Li L; Pang Z
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(38):3001-3004. PubMed ID: 29061007
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased levels of calprotectin in the saliva of patients with geographic tongue.
    Garsjö V; Dafar A; Jontell M; Çevik-Aras H; Bratel J
    Oral Dis; 2020 Apr; 26(3):558-565. PubMed ID: 31845422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ; Sydora BC; Fedorak RN
    J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA; Leach ST; Day AS
    Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.
    Ashorn S; Honkanen T; Kolho KL; Ashorn M; Välineva T; Wei B; Braun J; Rantala I; Luukkaala T; Iltanen S
    Inflamm Bowel Dis; 2009 Feb; 15(2):199-205. PubMed ID: 18618670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
    Bunn SK; Bisset WM; Main MJ; Golden BE
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.
    Kolho KL; Sipponen T; Valtonen E; Savilahti E
    Int J Colorectal Dis; 2014 Jan; 29(1):43-50. PubMed ID: 24077667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients.
    Vicente-Steijn R; Jansen JM; Bisheshar R; Haagen IA
    Pract Lab Med; 2020 Aug; 21():e00175. PubMed ID: 32637525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.